Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-10-05 Sale | 2026-10-05 5:12 pm | Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments | 4,126 | $57.1 | $235,595 | 19,020 (Indirect Direct) | View |
| 2026-09-28 Sale | 2026-09-30 4:32 pm | Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments | 4,126 | $57.88 | $238,813 | 23,146 (Indirect Direct) | View |
| 2026-09-22 Sale | 2026-09-24 4:10 pm | Royalty Pharma plc | RPRX | Hite Christopher EVP & Chairman, Partnering | 100,000 | $58.53 | $5,853,095 | 293,601 (Indirect Direct) | View |
| 2026-08-18 Sale | 2026-08-19 4:20 pm | Royalty Pharma plc | RPRX | Hite Christopher EVP & Chairman, Partnering | 100,000 | $59.97 | $5,997,250 | 393,601 (Indirect Direct) | View |
| 2026-08-13 Sale | 2026-08-17 5:01 pm | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 11,002 | $58.68 | $645,551 | 50,390 (Indirect Direct) | View |
| 2026-07-01 Sale | 2026-07-02 4:10 pm | Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments | 9,099 | $55.88 | $508,454 | 19,020 (Indirect Direct) | View |
| 2026-06-30 Sale | 2026-07-02 4:08 pm | Royalty Pharma plc | RPRX | Hite Christopher EVP & Chairman, Partnering | 130,000 | $56.5 | $7,345,471 | 499,399 (Indirect Direct) | View |
| 2026-06-24 Sale | 2026-06-25 5:13 pm | Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments | 9,098 | $55.18 | $502,067 | 9,099 (Direct) | View |
| 2026-06-23 Sale | 2026-06-25 5:11 pm | Royalty Pharma plc | RPRX | Hite Christopher EVP & Chairman, Partnering | 150,000 | $54.4 | $8,159,277 | 629,399 (Indirect Direct) | View |
| 2026-05-26 Sale | 2026-05-28 4:48 pm | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 64,399 | $53.98 | $3,476,116 | 50,390 (Indirect Direct) | View |
| 2026-05-20 Sale | 2026-05-21 9:20 pm | Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments | 13,684 | $52.75 | $721,838 | 37,217 (Indirect Direct) | View |
| 2026-05-14 Sale | 2026-05-15 4:38 pm | Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments | 13,684 | $53.06 | $726,137 | 50,901 (Indirect Direct) | View |
| 2026-05-14 Sale | 2026-05-15 4:37 pm | Royalty Pharma plc | RPRX | Norden Gregory Director | 3,045 | $53 | $161,385 | 191,803 (Direct) | View |
| 2026-04-28 Sale | 2026-04-30 5:54 pm | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 34,791 | $49.78 | $1,731,840 | 90,526 (Indirect Direct) | View |
| 2026-04-01 Sale | 2026-04-02 5:58 pm | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 34,791 | $48.33 | $1,681,512 | 83,306 (Indirect Direct) | View |
| 2026-03-23 Sale | 2026-03-25 5:05 pm | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 34,791 | $45.53 | $1,583,989 | 94,276 (Indirect Direct) | View |
| 2026-03-02 Sale | 2026-03-04 5:11 pm | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 34,791 | $46.78 | $1,627,534 | 96,151 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-11-04 Option Award | 2026-11-06 4:19 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 7,122 | $0 | 770,208 (Indirect) | View |
| 2026-11-06 Conversion | 2026-11-06 4:19 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 275,000 | $0 | 770,208 (Indirect) | View |
| 2026-11-04 Option Award | 2026-11-06 4:17 pm | N/A N/A | Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments | 5,341 | $0 | 403,773 (Direct) | View |
| 2026-11-06 Conversion | 2026-11-06 4:17 pm | N/A N/A | Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments | 165,000 | $0 | 403,773 (Indirect) | View |
| 2026-11-04 Option Award | 2026-11-06 4:15 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board | 42,209 | $0 | 4,954,404 (Direct) | View |
| 2026-11-04 Option Award | 2026-11-06 4:13 pm | N/A N/A | Royalty Pharma plc | RPRX | Hite Christopher EVP & Chairman, Partnering | 7,122 | $0 | 300,723 (Indirect) | View |
| 2026-09-30 Option Award | 2026-09-30 4:33 pm | N/A N/A | Royalty Pharma plc | RPRX | Bassler Bonnie L Director | 642 | $58.41 | 79,823 (Direct) | View |
| 2026-08-19 Gift | 2026-08-19 4:20 pm | N/A N/A | Royalty Pharma plc | RPRX | Hite Christopher EVP & Chairman, Partnering | 16,800 | $0 | 393,601 (Direct) | View |
| 2026-08-07 Gift | 2026-08-07 5:24 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board | 30,000 | $0 | 11,261,761 (Direct) | View |
| 2026-08-05 Option Award | 2026-08-07 5:24 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board | 65,216 | $0 | 11,261,761 (Direct) | View |
| 2026-08-07 Gift | 2026-08-07 5:24 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 18,500 | $0 | 1,850,169 (Indirect) | View |
| 2026-08-05 Option Award | 2026-08-07 5:24 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 11,002 | $0 | 1,850,169 (Indirect) | View |
| 2026-08-05 Option Award | 2026-08-07 5:12 pm | N/A N/A | Royalty Pharma plc | RPRX | Hite Christopher EVP & Chairman, Partnering | 11,002 | $0 | 510,401 (Indirect) | View |
| 2026-08-07 Gift | 2026-08-07 5:11 pm | N/A N/A | Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments | 3,000 | $0 | 271,684 (Indirect) | View |
| 2026-08-05 Option Award | 2026-08-07 5:11 pm | N/A N/A | Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments | 8,252 | $0 | 271,684 (Direct) | View |
| 2026-06-30 Option Award | 2026-06-30 5:15 pm | N/A N/A | Royalty Pharma plc | RPRX | Bassler Bonnie L Director | 689 | $54.4 | 79,181 (Direct) | View |
| 2026-06-05 Option Award | 2026-06-08 4:29 pm | N/A N/A | Royalty Pharma plc | RPRX | WEATHERMAN ELIZABETH H Director | 4,545 | $0 | 13,103 (Direct) | View |
| 2026-06-05 Option Award | 2026-06-08 4:28 pm | N/A N/A | Royalty Pharma plc | RPRX | Norden Gregory Director | 4,545 | $0 | 196,348 (Direct) | View |
| 2026-06-05 Option Award | 2026-06-08 4:27 pm | N/A N/A | Royalty Pharma plc | RPRX | LOVE TED W Director | 4,545 | $0 | 58,393 (Direct) | View |
| 2026-06-05 Option Award | 2026-06-08 4:26 pm | N/A N/A | Royalty Pharma plc | RPRX | HODGSON DAVID C Director | 4,545 | $0 | 37,873 (Direct) | View |
| 2026-06-05 Option Award | 2026-06-08 4:24 pm | N/A N/A | Royalty Pharma plc | RPRX | Ho Carole Director | 4,545 | $0 | 13,103 (Direct) | View |
| 2026-06-05 Option Award | 2026-06-08 4:22 pm | N/A N/A | Royalty Pharma plc | RPRX | Engelbert Catherine M. Director | 4,545 | $0 | 55,673 (Direct) | View |
| 2026-06-05 Option Award | 2026-06-08 4:21 pm | N/A N/A | Royalty Pharma plc | RPRX | Coric Vlad Director | 4,545 | $0 | 15,343 (Direct) | View |
| 2026-06-05 Option Award | 2026-06-08 4:20 pm | N/A N/A | Royalty Pharma plc | RPRX | Bassler Bonnie L Director | 4,545 | $0 | 78,492 (Direct) | View |
| 2026-05-06 Option Award | 2026-05-08 5:17 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board | 143,821 | $0 | 4,846,979 (Direct) | View |
| 2026-05-06 Option Award | 2026-05-08 5:14 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 24,263 | $0 | 114,789 (Indirect) | View |
| 2026-05-06 Option Award | 2026-05-08 5:12 pm | N/A N/A | Royalty Pharma plc | RPRX | Hite Christopher EVP & Vice Chairman | 24,263 | $0 | 779,399 (Indirect) | View |
| 2026-05-06 Option Award | 2026-05-08 5:10 pm | N/A N/A | Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments | 18,197 | $0 | 64,585 (Direct) | View |
| 2026-03-31 Option Award | 2026-03-31 4:09 pm | N/A N/A | Royalty Pharma plc | RPRX | Bassler Bonnie L Director | 815 | $45.98 | 73,947 (Direct) | View |